FDA reviewing Janssen's application to register COVID vaccine – DOH | Inquirer News

FDA reviewing Janssen’s application to register COVID vaccine – DOH

By: - Reporter / @zacariansINQ
/ 07:01 PM August 09, 2022

Peeling paint, shoddy cleanups among issues at US plant making J&J COVID-19 jab – FDA

FILE PHOTO: Vials of Johnson and Johnson’s Janssen coronavirus disease (COVID-19) vaccine are seen in an undated photograph. Johnson and Johnson/Handout via REUTERS

MANILA, Philippines —  The Department of Health (DOH) on Tuesday announced that the Food and Drug Administration (FDA) is reviewing an application from Janssen Biotech Inc. of Johnson and Johnson (J&J) for its COVID-19 vaccine.

“According to the FDA as of August 9, isa pa lang po na manufacturer ang nakapag-apply ng CPR sa kanila and this would be Janssen from J&J,” said DOH officer-in-charge Maria Rosario Vergeire during a media briefing.

ADVERTISEMENT

(According to the FDA, as of August 9, only one manufacturer has applied CPR to them; this would be Janssen from J&J.)

FEATURED STORIES

Vergeire said that the FDA is currently “reviewing and exercising the necessary work” for the application of Janssen.

A CPR, according to Vergeire will allow manufacturers to sell their products to the public even after lifting the state of calamity for COVID-19.

It can be recalled that the FDA approved Janssen’s COVID-19 vaccine emergency use authorization (EUA) in April 2021.

Meanwhile, Vergeire in the same briefing also bared factors that the DOH recommended the government consider before lifting the state of calamity in the country due to COVID-19.

This is about the state of calamity declared by former President Rodrigo Duterte, which will only last until September 2022.

The first consideration she said was the ongoing COVID-19 vaccination program. If the state of calamity is lifted, Republic Act 11525 or the act establishing the COVID-19 vaccination program will cease to exist.

ADVERTISEMENT

It will also terminate existing EUAs for other vaccines, only allowing those with CPRs to be used.

“Sa ngayon wala pa ho tayong ganung kadaming manufacturers applying so we need to work with our FDA and the other concerned agencies para may magapply na ng CPR,” said Vergeire.

(Right now, we don’t have that many manufacturers applying, so we need to work with our FDA and the other concerned agencies so that more can apply for CPR.)

“Eventually pag nagkaroon na ng CPR we will have our own certified vaccines na mga bakuna na pwede na gamitin kahit wala nang state of calamity,” she added.

(Eventually, when there is CPR, we will have our certified vaccines that can be used even if there is no state of calamity.)

She added that the government’s emergency procurement program will also be lifted, “and we won’t be able to expedite the medicines or vaccines we need when cases increase in hospitals.”

It will also lift tax exemptions on vaccine donors and manufacturers, price caps on testing kits and COVID-19 medicines, and the healthcare worker benefits due to COVID-19.

RELATED STORY:

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

Look to science before lifting COVID-19 state of calamity — Duque 

JPV/abc

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link.

TAGS: application, COVID-19, DoH, Health, Janssen, pandemic, registration, vaccine

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.